Advertisement

Index by author

February 01, 1994; Volume 45,Issue 2

A

  1. Abramovitz, M

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  2. Abramson, J J

    1. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin.
      G Liu, J J Abramson, A C Zable and I N Pessah
      Molecular Pharmacology February 1994, 45 (2) 189-200;

  3. Amin, J

    1. The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop.
      J Amin, I M Dickerson and D S Weiss
      Molecular Pharmacology February 1994, 45 (2) 317-323;

  4. Anand, R

    1. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
      V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology February 1994, 45 (2) 212-220;

  5. Anselment, A

    1. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
      J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
      Molecular Pharmacology February 1994, 45 (2) 335-340;

B

  1. Baez, M

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

  2. Ballesteros, J A

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  3. Bell, G I

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  4. Berkowitz, D

    1. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
      D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
      Molecular Pharmacology February 1994, 45 (2) 171-175;

  5. Blaxall, H S

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

  6. Bochkov, V N

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  7. Bock, M D

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  8. Boelsterli, U A

    1. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.
      A Kretz-Rommel and U A Boelsterli
      Molecular Pharmacology February 1994, 45 (2) 237-244;

  9. Borisova, Y L

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  10. Boujrad, N

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

  11. Braquet, P

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  12. Brauneis, U

    1. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
      K Masood, C Wu, U Brauneis and F F Weight
      Molecular Pharmacology February 1994, 45 (2) 324-329;

  13. Bühler, F R

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  14. Bylund, D B

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

C

  1. Calvert, A H

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  2. Caron, M G

    1. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
      D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
      Molecular Pharmacology February 1994, 45 (2) 171-175;

  3. Cerutis, D R

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

  4. Chabrier, P E

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  5. Chen, Y

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  6. Cho, A K

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  7. Cornet, S

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  8. Cromlish, W

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

D

  1. Davidson, J S

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  2. Dickerson, I M

    1. The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop.
      J Amin, I M Dickerson and D S Weiss
      Molecular Pharmacology February 1994, 45 (2) 317-323;

  3. Dietl, P

    1. Maitotoxin activates a nonselective cation channel and stimulates Ca2+ entry in MDCK renal epithelial cells.
      P Dietl and H Völkl
      Molecular Pharmacology February 1994, 45 (2) 300-305;

  4. Dimchev, A B

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

  5. Doble, A

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

E

  1. Eichler, J

    1. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
      J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
      Molecular Pharmacology February 1994, 45 (2) 335-340;

  2. Eshleman, A J

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

  3. Evans, V R

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

F

  1. Falgueyret, J P

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  2. Fardin, V

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  3. Flanagan, C

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

G

  1. Garnier, M

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

  2. Garret, C

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  3. Gerard, N P

    1. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
      C J Jensen, N P Gerard, T W Schwartz and U Gether
      Molecular Pharmacology February 1994, 45 (2) 294-299;

  4. Gerzanich, V

    1. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
      V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology February 1994, 45 (2) 212-220;

  5. Gether, U

    1. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
      C J Jensen, N P Gerard, T W Schwartz and U Gether
      Molecular Pharmacology February 1994, 45 (2) 294-299;

  6. Gillard-Roubert, V

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  7. Gonzalez, F J

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  8. Guilmard, C

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

H

  1. Hass, N A

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

  2. Henningsen, R A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

  3. Heuillet, E

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  4. Hirata, M

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  5. Hiratsuka, A

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  6. Hughes, L

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

I

  1. Itoh, S

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  2. Iversen, L J

    1. Cloning and expression of the alpha 2C-adrenergic receptor from the OK cell line.
      H S Blaxall, D R Cerutis, N A Hass, L J Iversen and D B Bylund
      Molecular Pharmacology February 1994, 45 (2) 176-181;

J

  1. Jackman, A

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  2. Janowsky, A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

  3. Jensen, C J

    1. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
      C J Jensen, N P Gerard, T W Schwartz and U Gether
      Molecular Pharmacology February 1994, 45 (2) 294-299;

  4. Johnson, M P

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

K

  1. Kamataki, T

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  2. Kanematsu, T

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  3. Kargman, S

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  4. Kennedy, B P

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  5. Kobayashi, S

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  6. Koga, T

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  7. Kong, H

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  8. Konvicka, K

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  9. Korzekwa, K R

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  10. Kretz-Rommel, A

    1. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.
      A Kretz-Rommel and U A Boelsterli
      Molecular Pharmacology February 1994, 45 (2) 237-244;

  11. Kumagai, Y

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  12. Kuzmenko, Y S

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  13. Kwan, M Y

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

L

  1. Langenstroer, P

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  2. Lefkowitz, R J

    1. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
      D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
      Molecular Pharmacology February 1994, 45 (2) 171-175;

  3. Le Guern, J

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  4. Lepor, H

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  5. Lin, L Y

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  6. Lindstrom, J

    1. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
      V Gerzanich, R Anand and J Lindstrom
      Molecular Pharmacology February 1994, 45 (2) 212-220;

  7. Liu, G

    1. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin.
      G Liu, J J Abramson, A C Zable and I N Pessah
      Molecular Pharmacology February 1994, 45 (2) 189-200;

  8. Loncharich, R J

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

M

  1. Mancini, J A

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  2. Masaki, K

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  3. Masood, K

    1. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
      K Masood, C Wu, U Brauneis and F F Weight
      Molecular Pharmacology February 1994, 45 (2) 324-329;

  4. Massoulié, J

    1. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
      J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
      Molecular Pharmacology February 1994, 45 (2) 335-340;

  5. Mayaux, J F

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  6. Ménager, J

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  7. Millar, R P

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  8. Min, C K

    1. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
      C K Min, J Owens and G A Weiland
      Molecular Pharmacology February 1994, 45 (2) 221-227;

  9. Moran, R G

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  10. Musto, N A

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

N

  1. Narimatsu, S

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  2. Narumoto, N

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  3. Nelson, D L

    1. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
      M P Johnson, R J Loncharich, M Baez and D L Nelson
      Molecular Pharmacology February 1994, 45 (2) 277-286;

  4. Nemec, J

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  5. Neve, K A

    1. Release of dopamine via the human transporter.
      A J Eshleman, R A Henningsen, K A Neve and A Janowsky
      Molecular Pharmacology February 1994, 45 (2) 312-316;

O

  1. O'Neill, G P

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  2. Oguri, K

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  3. Opgenorth, T

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  4. Ouellet, M

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  5. Owens, J

    1. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
      C K Min, J Owens and G A Weiland
      Molecular Pharmacology February 1994, 45 (2) 221-227;

  6. Ozaki, S

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

P

  1. Papadopoulos, V

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

  2. Pessah, I N

    1. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin.
      G Liu, J J Abramson, A C Zable and I N Pessah
      Molecular Pharmacology February 1994, 45 (2) 189-200;

  3. Pirotzky, E

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  4. Plas, P

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  5. Pourmarin, L

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

  6. Pradier, L

    1. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
      L Pradier, J Ménager, J Le Guern, M D Bock, E Heuillet, V Fardin, C Garret, A Doble and J F Mayaux
      Molecular Pharmacology February 1994, 45 (2) 287-293;

  7. Price, D T

    1. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
      D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
      Molecular Pharmacology February 1994, 45 (2) 171-175;

  8. Price, J M

    1. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.
      M Garnier, A B Dimchev, N Boujrad, J M Price, N A Musto and V Papadopoulos
      Molecular Pharmacology February 1994, 45 (2) 201-211;

R

  1. Raynor, K

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  2. Reisine, T

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  3. Relling, M V

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  4. Resink, T J

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  5. Roubert, P

    1. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure.
      P Roubert, V Gillard-Roubert, L Pourmarin, S Cornet, C Guilmard, P Plas, E Pirotzky, P E Chabrier and P Braquet
      Molecular Pharmacology February 1994, 45 (2) 182-188;

S

  1. Sakuma, T

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  2. Sanghani, P C

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  3. Schuetz, E G

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  4. Schuetz, J D

    1. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
      M V Relling, J Nemec, E G Schuetz, J D Schuetz, F J Gonzalez and K R Korzekwa
      Molecular Pharmacology February 1994, 45 (2) 352-358;

  5. Schwartz, T W

    1. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
      C J Jensen, N P Gerard, T W Schwartz and U Gether
      Molecular Pharmacology February 1994, 45 (2) 294-299;

  6. Schwinn, D A

    1. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology.
      D T Price, R J Lefkowitz, M G Caron, D Berkowitz and D A Schwinn
      Molecular Pharmacology February 1994, 45 (2) 171-175;

  7. Sealfon, S C

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  8. Shapiro, E

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  9. Silman, I

    1. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
      J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
      Molecular Pharmacology February 1994, 45 (2) 335-340;

  10. Sussman, J L

    1. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
      J Eichler, A Anselment, J L Sussman, J Massoulié and I Silman
      Molecular Pharmacology February 1994, 45 (2) 335-340;

  11. Suzuki, T

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

T

  1. Tang, R

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  2. Thornton, T

    1. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
      P C Sanghani, A Jackman, V R Evans, T Thornton, L Hughes, A H Calvert and R G Moran
      Molecular Pharmacology February 1994, 45 (2) 341-351;

  3. Tkachuk, V A

    1. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells.
      V N Bochkov, V A Tkachuk, Y S Kuzmenko, Y L Borisova, F R Bühler and T J Resink
      Molecular Pharmacology February 1994, 45 (2) 262-270;

  4. Toews, M L

    1. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
      S J Zhu and M L Toews
      Molecular Pharmacology February 1994, 45 (2) 255-261;

V

  1. Völkl, H

    1. Maitotoxin activates a nonselective cation channel and stimulates Ca2+ entry in MDCK renal epithelial cells.
      P Dietl and H Völkl
      Molecular Pharmacology February 1994, 45 (2) 300-305;

W

  1. Wang, B

    1. Binding and functional properties of endothelin receptor subtypes in the human prostate.
      S Kobayashi, R Tang, B Wang, T Opgenorth, P Langenstroer, E Shapiro and H Lepor
      Molecular Pharmacology February 1994, 45 (2) 306-311;

  2. Watanabe, Y

    1. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
      M Hirata, N Narumoto, Y Watanabe, T Kanematsu, T Koga and S Ozaki
      Molecular Pharmacology February 1994, 45 (2) 271-276;

  3. Weight, F F

    1. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
      K Masood, C Wu, U Brauneis and F F Weight
      Molecular Pharmacology February 1994, 45 (2) 324-329;

  4. Weiland, G A

    1. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
      C K Min, J Owens and G A Weiland
      Molecular Pharmacology February 1994, 45 (2) 221-227;

  5. Weinstein, H

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  6. Weiss, D S

    1. The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop.
      J Amin, I M Dickerson and D S Weiss
      Molecular Pharmacology February 1994, 45 (2) 317-323;

  7. Wu, C

    1. Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits.
      K Masood, C Wu, U Brauneis and F F Weight
      Molecular Pharmacology February 1994, 45 (2) 324-329;

Y

  1. Yamada, H

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  2. Yasuda, K

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

  3. Yergey, J

    1. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
      G P O'Neill, J A Mancini, S Kargman, J Yergey, M Y Kwan, J P Falgueyret, M Abramovitz, B P Kennedy, M Ouellet and W Cromlish
      Molecular Pharmacology February 1994, 45 (2) 245-254;

  4. Yokoi, T

    1. Sex-related differences in the expression of cytochrome P450 in hamsters: cDNA cloning and examination of the expression of three distinct CYP2C cDNAs.
      T Sakuma, K Masaki, S Itoh, T Yokoi and T Kamataki
      Molecular Pharmacology February 1994, 45 (2) 228-236;

  5. Yoshimura, H

    1. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
      Y Kumagai, L Y Lin, A Hiratsuka, S Narimatsu, T Suzuki, H Yamada, K Oguri, H Yoshimura and A K Cho
      Molecular Pharmacology February 1994, 45 (2) 359-365;

  6. Yu, L

    1. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
      K Raynor, H Kong, Y Chen, K Yasuda, L Yu, G I Bell and T Reisine
      Molecular Pharmacology February 1994, 45 (2) 330-334;

Z

  1. Zable, A C

    1. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin.
      G Liu, J J Abramson, A C Zable and I N Pessah
      Molecular Pharmacology February 1994, 45 (2) 189-200;

  2. Zhou, W

    1. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.
      W Zhou, C Flanagan, J A Ballesteros, K Konvicka, J S Davidson, H Weinstein, R P Millar and S C Sealfon
      Molecular Pharmacology February 1994, 45 (2) 165-170;

  3. Zhu, S J

    1. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
      S J Zhu and M L Toews
      Molecular Pharmacology February 1994, 45 (2) 255-261;
Back to top

In this issue